Why Do Class I/II Brazilian Medical Devices Have No Physical Certificates, While Class III/IV Do?
Views：55
Time：2026-08-11 14:13:16
Many medical device exporters developing the Brazilian market receive a screenshot from ANVISA’s official website provided by freight forwarders or compliance consultants, mistakenly taking it as an official Brazilian medical device registration certificate. Today, based on a real ANVISA public inquiry page for Class II medical devices, we will break down all details on the page and systematically sort out core registration rules for low-to-medium-risk Class I and Class II medical devices in Brazil. We will also distinguish between web inquiry records and physical registration certificates to help you avoid clearance failures and audit risks from local distributors and hospitals. 一、Basic Definition of This Web Page
The page header reads Consultas ANVISA - Agência Nacional de Vigilância Sanitária, which translates to the official product inquiry system of Brazil’s National Health Surveillance Agency.Application Scenario：Anyone can access the public inquiry portal on ANVISA’s official website and retrieve records by entering notification numbers, the Brazilian importer’s CNPJ tax ID or product keywords. All data shown is publicly verifiable official information.Core Misconception：Class III and Class IV high-risk medical devices are issued standalone PDF registration certificates with Brazil’s national emblem and official stamps.No separate paper or electronic certificates are issued for Class I and Class II devices. Printed copies of this official web page are the only legally recognized compliance document accepted by Brazilian customs, local distributors and medical institutions.Uniform Page Template Rule：All Class I and Class II notified medical devices in Brazil share this identical fixed table template on the inquiry system. No fields will be added or removed — only product-specific information varies.二、Full Breakdown of Information on the Public Inquiry Page
Nome da Empresa Detentora da Notificação：Notification Holder Company NameRegulatory Rule: Brazilian laws prohibit overseas manufacturers from holding ANVISA notifications directly. You must appoint a locally registered Brazilian legal entity with valid medical device import qualifications as your notification holder.
Holder Responsibilities: Manage after-sales services in Brazil, report adverse events, submit regulatory updates, coordinate customs clearance. Overseas manufacturers have no direct communication channel with ANVISA. CNPJ do Detentor da Notificação：Notification Holder’s Brazilian Tax IDThe CNPJ number serves as the unique identity code for Brazilian enterprises. During customs and ANVISA compliance checks, the tax ID must match the notification holder; mismatches will result in cargo detention. Autorização de Funcionamento da Empresa：Company Operation Authorization NumberThis is a mandatory pre-requisite qualification, also known as the AFE certificate: a national license for Brazilian companies to import and distribute medical devices. Entities without a valid AFE certificate cannot act as notification holders for Class I/II devices. Nome do Dispositivo Médico / Nome Técnico do Dispositivo Médico：Commercial & Technical Product NameCritical Compliance Red Line: Product names printed on outer packaging, instructions and customs declaration documents must fully match the names registered on this inquiry page. Inconsistent naming will be deemed a mismatch between cargo and notification, blocking customs release. Número da Notificação：Notification NumberKey Identification Marker: Low/medium-risk Class I & II devices carry a Notificação (Notification Number). High-risk Class III & IV devices use a Número do Registro (Registration Number). The two sets of numbers follow different coding formats, allowing instant risk classification at a glance. Situação da Notificação：Notification StatusCommon status definitions:
Válido: Valid; eligible for import and commercial sales
Processo da Notificação：Official File Reference NumberANVISA’s internal archive ID, used to locate the original notification dossier when submitting amendments, annual updates or adverse event reports. Fabricante Legal do Dispositivo Médico：Legal Manufacturer InformationMandatory Requirement: The registered production address must fully align with the actual manufacturing site and the address stated on the ISO 13485 certificate. Additional production facilities require separate amendment submissions. Classificação de Risco do Dispositivo Médico：Device Risk ClassificationANVISA implements a four-tier risk classification system for medical devices:
Classe II: Medium risk, short-term invasive devices (endoscopic injection needles, single-use syringes, basic minimally invasive consumables, the category of the sample product in this article)
Classe III: High risk, long-term invasive products contacting the circulatory system (catheters, partially implantable devices)
Classe IV: Highest risk, permanently implanted devices, life-support equipment, active implantable medical devices
Data de Início da Vigência：Effective Start DateBrazilian date format follows DD/MM/YYYY. For example, 01/06/2026 means the notification officially takes effect on June 1, 2026. Cargo cannot be imported or cleared before this date. Data de Vencimento da Notificação：Notification Expiry DateCore Difference Between Class I/II and Class III/IV:
Class I & II Notificação Notification: No fixed expiry date, valid indefinitely. The page uniformly displays VIGENTE (Current Valid) without an expiration date, on the condition that annual updates are filed each year.
Class III & IV Registro Registration: Valid for 10 years with a clear printed expiry date on the inquiry page. Renewal applications must be submitted in advance; registrations expire automatically if renewal is missed.
三、Core Regulatory Rules for Class I & II Medical Device Notifications in Brazil
（一）Application Route: Notification System ≠ Full Registration System, Simplified Procedures
ANVISA adopts tiered supervision for medical devices:
Class I & II low/medium-risk devices: Follow the Notificação notification system — a self-declaration regulatory framework. ANVISA does not conduct in-depth technical reviews, and notifications are issued rapidly once complete documents are submitted.
Class III & IV high-risk devices: Require full Registro registration. Complete clinical trial data, biocompatibility and toxicology test documentation are mandatory, with lengthy official review cycles.
（二） Mandatory Requirements for Notification HoldersOverseas manufacturers cannot hold notifications independently. You must appoint a Brazilian local entity holding a valid AFE import license as the notification holder, who bears full legal regulatory responsibilities within Brazilian territory. （三） Mandatory Annual Filing ObligationThough Class I/II notifications remain valid indefinitely, the Brazilian holder must submit an annual update report to ANVISA every year, disclosing annual sales volumes, adverse event records and factory change information. Failure to submit annual filings for consecutive years will lead to automatic notification revocation. （四）The Official Inquiry Page Is the Sole Valid Customs Clearance DocumentA frequently asked question: Can we apply for an official paper certificate?
ANVISA regulations explicitly state that no standalone physical certificates are issued for Class I and II notifications. For customs clearance, distributor audits and customer compliance verification, a printed copy of this official inquiry page together with the Brazilian importer’s AFE license constitutes complete compliance documentation.
By contrast, Class III and IV products receive an independent stamped PDF registration certificate featuring the Brazilian national emblem — a document with a completely different format that cannot be confused with the notification inquiry page. （五）Strict Amendment Control: All Information Changes Require Official SubmissionThe Brazilian notification holder must file an amendment application with ANVISA within 30 days if any of the following information changes:
Product name, model specifications or raw material composition
Manufacturing factory address or production processes
Notification holder (local Brazilian importer) replacement
Failure to declare amendments before continued sales will result in cargo seizure and substantial fines.
四、Conclusion
Brazil ranks as Latin America’s largest medical device consumer market. Many foreign trade practitioners confuse ANVISA notifications with formal registrations, or mistake inquiry screenshots for official certificates. For Class I and II low-to-medium-risk consumables, the official ANVISA inquiry page carries full legal validity as your compliance proof. However, "indefinite validity" does not mean zero maintenance obligations — annual filings, timely amendment declarations and full consistency between declared and shipped product names demand strict attention at all times.For further inquiries, please contact Wiselink.
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.
